We are live on
!
Find out more
Plus Therapeutics
PSTV
PSTV
9 hedge funds and large institutions have $1.28M invested in Plus Therapeutics in 2019 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
36% more capital invested
Capital invested by funds: $941K → $1.28M (+$338K)
0.1% less ownership
Funds ownership: 0.13% → 0.04% (-0.1%)
18% less funds holding
Funds holding: 11 → 9 (-2)
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
Holders
9
Holders Change
-2
Holders Change %
-18.18%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
3
Reduced
–
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
+$295K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$294K |
| 3 |
Renaissance Technologies
New York
|
+$124K |
| 4 |
Bank of New York Mellon
New York
|
+$70.5K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$50.4K |
Top Sellers
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$134K |
| 2 |
Citigroup
New York
|
-$115K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$101K |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$41K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$38K |
